相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution
E. Brissot et al.
BONE MARROW TRANSPLANTATION (2016)
Autologous transplant remains the preferred therapy for relapsed APL in CR2
C. Ganzel et al.
BONE MARROW TRANSPLANTATION (2016)
Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia
J. Parigger et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Targeted Therapy Alone for Acute Promyelocytic Leukemia
Francesco Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide
David Sanford et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet
E. Lengfelder et al.
LEUKEMIA (2015)
Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
Yinjun Lou et al.
ANNALS OF HEMATOLOGY (2014)
Extramedullary disease in APL: A real phenomenon to contend with or not?
Chezi Ganzel et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2014)
Autologous Is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission
Jennifer L. Holter Chakrabarty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
Alan S. Gamis et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia
Hong-Hu Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Outcome of Children Treated for Relapsed Acute Myeloid Leukemia in Central America
Stacey Marjerrison et al.
PEDIATRIC BLOOD & CANCER (2014)
Treatment of an Acute Promyelocytic Leukemia Relapse Using Arsenic Trioxide and All-Trans-Retinoic in a 6-Year-Old Child
Nathalie Rock et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2014)
Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia
Masamitsu Yanada et al.
BLOOD (2013)
Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: A retrospective analysis of JALSG-APL97
Hiroyuki Fujita et al.
CANCER SCIENCE (2013)
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
Naveen Pemmaraju et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129
Dan Douer et al.
LEUKEMIA RESEARCH (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
Harry J. Iland et al.
BLOOD (2012)
Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease
Massimo Breccia et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era
Safaa M. Ramadan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group
Cecile Bally et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
Sylvie Castaigne et al.
LANCET (2012)
Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients
Wing Y. Au et al.
PEDIATRIC BLOOD & CANCER (2012)
Sustained Molecular Remission after Arsenic Trioxide and Gemutuzumab Ozogamicin in a Pediatric Patient with Relapsed Acute Promyelocytic Leukemia
Akiko Inoue et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2012)
Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia
Massimo Breccia et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Long-Term Remission After First-Line Single-Agent Treatment with Arsenic Trioxide of Relapsed Acute Promyelocytic Leukemia in an 8-Year-Old Boy
Martin Ebinger et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2011)
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
Lionel Ades et al.
BLOOD (2010)
Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia
Jin Zhou et al.
BLOOD (2010)
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
Francesco Lo-Coco et al.
BLOOD (2010)
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses
Ursula Creutzig et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
Vikram Mathews et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide-Based Regimen
Rajasekar Thirugnanam et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2009)
Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy
David Grimwade et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
Farhad Ravandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Central Nervous System Involvement in Relapsed Acute Promyelocytic Leukemia
Gertjan Kaspers et al.
PEDIATRIC BLOOD & CANCER (2009)
Isolated Central Nervous System Recurrence of Acute Promyelocytic Leukemia in Children
Jessica Chow et al.
PEDIATRIC BLOOD & CANCER (2009)
Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
Christopher C. Dvorak et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
Elizabeth Fox et al.
BLOOD (2008)
Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission: a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
Akio Kohno et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Isolated central nervous system relapse in childhood acute promyelocytic leukemia
Katrin Scheinemann et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment
Wing-Yan Au et al.
LEUKEMIA RESEARCH (2008)
Presentation of acute promyelocytic leukemia as granulocytic sarcoma
Jennifer Worch et al.
PEDIATRIC BLOOD & CANCER (2008)
Mobilization of PML-RARA negative blood stem cells and salvage with autologous peripheral blood stem cell transplantation in children with relapsed acute promyelocytic leukemia
Amanda M. Termuhlen et al.
PEDIATRIC BLOOD & CANCER (2008)
Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: A single center experience
Li Zhang et al.
PEDIATRIC BLOOD & CANCER (2008)
Acute promyelocytic leukemia: Recent advances in diagnosis and management
Francesco Lo-Coco et al.
SEMINARS IN ONCOLOGY (2008)
Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy
Guang-Biao Zhou et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2007)
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project
June M. McKoy et al.
LEUKEMIA RESEARCH (2007)
Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose anti metabolite-based chemotherapy
Christopher C. Dvorak et al.
PEDIATRIC BLOOD & CANCER (2007)
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation
M. A. Sanz et al.
BONE MARROW TRANSPLANTATION (2007)
Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia
Ahmed Aribi et al.
CANCER (2007)
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99):: benefit of an early intervention
J. Esteve et al.
LEUKEMIA (2007)
Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemia
Massimo Breccia et al.
HAEMATOLOGICA (2007)
Late relapses in acute promyelocytic leukaemia
Roberto Latagliata et al.
ACTA HAEMATOLOGICA (2007)
Recurrent extramedullary relapse of acute promyelocytic leukemia after allogeneic stem cell transplantation: Successful treatment by arsenic trioxide in combination with local radiotherapy
T Kai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
S de Botton et al.
LEUKEMIA (2006)
Treatment with all-trans retinoic acid and anthracycline mono chemotherapy for children with acute promyelocytic leukemia:: A multicenter study by the PETHEMA group
JJ Ortega et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: Updated outcomes of the phase II study and postremission therapies
K Shigeno et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children
AM Testi et al.
BLOOD (2005)
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: A retrospective analysis of the European acute promyelocytic leukemia group
S de Botton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy
S de Botton et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Late relapse of acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy:: report of two cases
F Ferrara et al.
ANNALS OF HEMATOLOGY (2004)
Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood
JP Bourquin et al.
BONE MARROW TRANSPLANTATION (2004)
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
F Lo-Coco et al.
BLOOD (2004)
New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFB-MYH11+ acute myeloid leukemia based on quantification of fusion transcripts
S Schnittger et al.
BLOOD (2003)
Quantitative real-time RT-PCR analysis of PML-RARα-mRNA in acute promyelocytic leukemia:: assessment of prognostic significance in adult patients from intergroup protocol 0129
RE Gallagher et al.
BLOOD (2003)
Experience with gemtuzumab ozogamycin (mylotarg), and all-trans retinoic acid in untreated acute promyelocytic leukemia
EH Estey et al.
BLOOD (2002)
Unusual sites of involvement by hematologic malignancies - Case 3. External auditory canal tumor: A rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide
WY Au et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
SL Soignet et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
